Clinical trial
Immunomodulatory Effect of Pleuran (β-glucan From Pleurotus Ostreatus) in Children With Recurrent Respiratory Tract Infections
NCT06974747 is registered in ClinicalTrials.gov with Pleuran, s.r.o. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunomodulatory Effect of Pleuran (β-glucan From Pleurotus Ostreatus) in Children With Recurrent Respiratory Tract Infections
- Lead sponsor
- Pleuran, s.r.o.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 25, 2023
- Completion date
- March 31, 2024
- Enrollment
- 217 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
respiratory tract infection